Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Acquiring Company
GE HealthCare Technologies
Acquired Company
SOFIE Biosciences
Description
GE HealthCare Technologies has announced a definitive agreement to acquire SOFIE Biosciences for $945 million in cash. This acquisition enhances GE HealthCare's capabilities in the U.S. PET radiopharmaceutical market and includes rights to a novel imaging candidate. The deal is expected to strengthen GE HealthCare’s position in cancer diagnostics and imaging solutions.
Fundz sees it the moment GE HealthCare Technologies makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired SOFIE Biosciences?
SOFIE Biosciences was acquired by GE HealthCare Technologies, based in Chicago. The deal was reported on October 13, 2026. GE HealthCare Technologies Inc. is a global medical technology company specializing in pharmaceutical diagnostics, imaging analytics, and digital solutions. GE HealthCare Technologies is publicly traded (GEHC) and operates in Other.
When did GE HealthCare Technologies acquire SOFIE Biosciences?
GE HealthCare Technologies's acquisition of SOFIE Biosciences was reported on October 13, 2026. GE HealthCare Technologies has announced a definitive agreement to acquire SOFIE Biosciences for $945 million in cash. This acquisition enhances GE HealthCare's capabilities in the U.S. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does SOFIE Biosciences do?
SOFIE Biosciences is a leading innovator in the field of radiopharmaceuticals. The company develops advanced imaging agents for cancer diagnosis and treatment. Its products aim to improve the accuracy and effectiveness of diagnostic imaging. It is privately held, operating in Biotechnology, and is based in Culver City.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.